Posner et al., 1981 - Google Patents
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas.Posner et al., 1981
View PDF- Document ID
- 2603795079678531396
- Author
- Posner L
- Robert-Guroff M
- Kalyanaraman V
- Poiesz B
- Ruscetti F
- Fossieck B
- Bunn Jr P
- Minna J
- Gallo R
- Publication year
- Publication venue
- The Journal of experimental medicine
External Links
Snippet
Sera from patients with cutaneous T cell lymphoma and leukemia were screened for the presence of natural antibody to the human T cell lymphoma (leukemia) virus, HTLVCR, using a solid-phase radioimmunoassay. Sera from two patients, including patient CR, from …
- 241000700605 Viruses 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from micro-organisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Posner et al. | Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. | |
| Parks et al. | Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide | |
| Barbacid et al. | Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. | |
| Kalyanaraman et al. | Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus | |
| Robey et al. | Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. | |
| Lee et al. | Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. | |
| EP0196319B1 (en) | Retroviral polypeptides associated with human cellular transformation | |
| US5055391A (en) | Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2) | |
| Bex et al. | Humoral antibody response to bovine leukemia virus infection in cattle and sheep | |
| CA1338501C (en) | Method of detecting antibody against htlv-iii | |
| Strand et al. | Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus | |
| JPH07121959B2 (en) | HTLV-III III Envelope protein | |
| US5364933A (en) | Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) | |
| GB2196634A (en) | Monoclonal antibodies to HIV and related peptides | |
| Metzgar et al. | Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. | |
| Robert-Guroff et al. | Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody | |
| US6531574B1 (en) | T-lymphotrophic virus | |
| Sano et al. | Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus | |
| US5268265A (en) | Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV | |
| Hadlock et al. | Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II | |
| Newgard et al. | Human antibodies binding to the mouse mammary tumor virus: A nonspecific reaction? | |
| Kittelberger et al. | Evaluation of electrophoretic immunoblotting for the detection of antibodies against the bovine leukosis virus in cattle | |
| Devare et al. | Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates | |
| Sibille et al. | Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats | |
| Derks et al. | Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with Simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient |